4 - Management of Complications in DM

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/47

encourage image

There's no tags or description

Looks like no tags are added yet.

48 Terms

1
New cards

What is the foundation and pillars of diabetes management?

Foundation → lifestyle modification and diabetes education

Pillars → Glycemic, BP, and lipid management and agents with cardiovascular/kidney benefit

2
New cards

Macrovascular complications of diabetes?

ASCVD → myocardial infraction (MI), cerebrovascular accident (CVA), Peripheral artery disease (PAD)

Heart failure

3
New cards

Microvascular complications of diabetes?

Nephropathy/CKD

Neuropathy

Retinopathy

4
New cards

When to screen for A1c with diabetes?

Every 3-6 months

5
New cards

When to screen for UACR with diabetes?

Yearly

6
New cards

When to screen for dilated eye exam with diabetes?

Yearly to every 2 years depending on risk

7
New cards

When to screen for lipid panel with diabetes?

Yearly

8
New cards

When to screen for creatinine with diabetes?

Yearly or more frequent depending on medication use → metformin/SGLT2i

9
New cards

Physical assessment screening for diabetes?

Blood pressure → regularly

Foot exam → Yearly

10
New cards

When to start screenings for T1D?

Can wait 5 years after diagnosis for regular screens → unless other risk factors

11
New cards

When to start screenings for T2D?

Start screenings right away

12
New cards

Why are personalized A1c goals important?

To balance glucose control with the risk of hypoglycemia and other side effects

13
New cards

At what A1c level does the risk of complications consistently increase?

A1c > 8.0% consistently

14
New cards

Goal blood pressure in diabetes?

<130/80 mmHg

15
New cards

What if BP of above >150/90 in diabetes?

Start 2 preferred agents:

  • ACE/ARB

  • CCB → amlodipine/nifedipine

  • Thiazide diuretic → chlorthalidone/indapamide preferred


16
New cards

What is diabetes considered in ASCVD risk assessment?

Diabetes is an ASCVD risk-enhancing factor

17
New cards

Lipid management primary prevention in patients with DM age 40-75?

Moderate intensity statin



18
New cards

LDL goal for primary prevention in patients with DM age 40-75 with PREVENT-ASCVD < 10%?

Goal LDL < 100

19
New cards

LDL goal for primary prevention in patients with DM age 40-75 with PREVENT-ASCVD ≥ 10%?

Goal LDL < 70

Typically means multiple ASCVD risk factors

20
New cards

Lipid management secondary prevention in patients with DM?

High intensity statin

Consider a 50% LDL lowering and/or LDL <50

21
New cards

Moderate intensity statin therapy?

Lowers LDL → 30-49%

Atorvastatin 10-20 mg

Rosuvastatin 5-10 mg

Simvastatin 20-40 mg

Pravastatin 40-80 mg

Lovastatin 40-80 mg

Fluvastatin XL 80 mg

Pitavastatin 1-4 mg

22
New cards

High intensity statin therapies?

Atorvastatin 40-80 mg

Rosuvastatin 20-40 mg

23
New cards

What if unable to reach LDL goals?

2nd therapies include →

Ezetimibe

PCSK9 inhibitors

Bempedoic acid is recommended IF they are statin intolerant

24
New cards

What if they have ASCVD or high risk indicators?

Use →
SGLTi

GLP-1 receptor agonists → Semaglutide/Dulaglutide

GIP/GLP combo agonist → Tirzepatide

Pioglitazone → LAST LINE, avoid in HF

25
New cards

What if they have heart failure?

Prioritize SGLT2 inhibitors

Then → Semaglutide, Tirzepatide, especially in HFpEF and obesity

26
New cards

What if they have CKD?

On max tolerated dose of ACE/ARB

Then use → SGLT2i most favorable

  • Especially with common complications in diabetes

    • Albuminuria/Proteinuria

    • UACR of >30mg/g

    • Even if eGFR is >60ml/min


27
New cards

When do you consider finerenone in CKD?

Simultaneous initiation of an SGLT2 inhibitor and a nonsteroidal MRA (finerenone) can be considered in adults with type 2 diabetes already on max tolerated RAAS inhibition therapy if →

AND: UACr ≥100 mg/g

AND: eGFR 30–90 mL/min/1.73 m2

Make sure Potassium is not super elevated before initiation (ideal < 4.8 mEq/L, monitor closely if 4.9-5.0 mEq/L

28
New cards

First line neuropathic pain treatment options?

Pregabalin / Gabapentin

SNRIs → duloxetine, venlafaxine

TCAs → amitriptyline

Sodium channel blockers → lamotrigine, lacosamide, carbamazepine, oxcarbazepine, valproic acid

29
New cards

Addition options for neuropathic pain treatment?

Capsaicin

Lidocaine patches

Alpha-lipoic acid

30
New cards

What to keep in mind with neuropathic pain treatment options?

The agents provides symptomatic improvement but do not prevent/reverse progression

Better blood glucose may slow progression but cannot reverse neuronal loss

31
New cards

When is aspirin considered for primary prevention in patients with diabetes?

Typically not recommended; individual risk/benefit discussion

May consider ages 50–69 with at least one additional ASCVD risk factor and no increased bleeding risk

32
New cards

What additional risk factors support considering aspirin for primary prevention?

Family history of premature ASCVD

Hypertension

Dyslipidemia

Smoking

CKD/albuminuria

33
New cards

When is aspirin recommended for secondary prevention?

Recommended → aspirin 81 mg daily

34
New cards

What causes diabetic neuropathy?

Increased blood glucose leads to insulin resistance, dyslipidemia, and oxidative stress

These cause inflammation and cellular damage to nerve fibers

35
New cards

Symptoms of peripheral neuropathy?

Burning

Sharp pain

Cold sensation

Numbness

Up to 50% may be asymptomatic

36
New cards

Symptoms of autonomic neuropathy?

Orthostatic hypotension, dizziness

Resting tachycardia

Dry or cracked skin in the extremities

Gastroparesis, constipation, diarrhea

Erectile dysfunction

37
New cards

Neuropathy screening?

At least annually

Peripheral neuropathy → foot exam

Autonomic neuropathy → monitor for symptoms

38
New cards

Foot exam dermatologic inspection?

Skin status

Sweating

Infection

Ulceration

Calluses/blistering

39
New cards

Foot exam musculoskeletal inspection?

Deformities

Muscle wasting

40
New cards

Foot exam neurological assessment?

10-g monofilament plus 1 of the following →

• Vibration using 128-Hz tuning fork

• Pinprick sensation

• Ankle reflexes

• Vibration perception threshold (VPT)

41
New cards

Foot exam vascular assessment?

Foot pulses

Ankle brachial index → if indicated

42
New cards

Retinopathy?

Hyperglycemia and/or uncontrolled blood pressure damage the blood vessels supplying the retina

43
New cards

Retinopathy screening and treatment?

Screening → Annually with dilated eye exam, can be spread out every 2 years

Treatment → No specific pharmacotherapy recommended to treat / prevent progression, just controlling glucose concentrations and BP

44
New cards

What eye complication has been associated with SQ semaglutide (Ozempic)?

Increased incidence of diabetic retinopathy complications

45
New cards

What is NAION?

Non-arteritic anterior ischemic optic neuropathy

11/26 → warning added to all GLP-1 products

46
New cards

What is the proposed mechanism behind GLP-1-related eye complications?

Rapid improvement in hyperglycemia → especially in patients with uncontrolled diabetes

47
New cards

What are the risk factors for diabetic retinopathy complications with GLP-1 therapy?

Pre-existing diabetic retinopathy

Large (>1.5%) and rapid (≤16 weeks) A1c reduction

48
New cards

Which vaccines are recommended for adults with diabetes?

Hepatitis B → ages 19–59

Pneumococcal → PCV20 or PCV21

RSV → consider for adults >60 due to increased risk

And Tdap, Shingles, influenza, covid-19 per normal adult schedule